104 completed, 20 unknown, 12 recruiting, 9 terminated. 52 Phase 4, 31 Phase 3, 23 Not applicable, 20 Phase 1, 14 Phase 2.
Follow Solifenacin Succinate: new trials by email Literature Review of Solifenacin Succinate trials Research Report on Solifenacin Succinate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate) Vesomni - Benign Prostatic Hyperplasia | Not yet recruiting | Astellas Pharma Korea, Inc. | 600 | 2026-11-30 | 2026-10-15 | |
| Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms Solifenacin, Melatonin - Ureteral Stent-Related Symptoms, Ureteral Calculi | Phase 2 | Recruiting | Beni-Suef University | 189 | 2026-05-07 | 2026-06-02 |
| Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet urotherapy, Solifenacin Succinate, Vitamin D3 - Urinary Bladder, Overactive, Overactive Bladder | Not applicable | Recruiting | Children's Hospital of Chongqing Medical University | 180 | 2026-04-20 | 2026-04-17 |
| Mirabegron in Patients With Age-Related Macular Degeneration Mirabegron 50mg, Solifenacin 5mg - Dry AMD, Overactive Bladder | Not yet recruiting | University of Naples | 312 | 2026-04-01 | 2026-02-06 | |
| Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg - Overactive Bladder (OAB), Urge Incontinence | Phase 4 | Recruiting | Mansoura University | 70 | 2025-11-11 | 2026-03-16 |
| Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study Tadalafil 5 mg, Solifenacin 5mg - Overactive Bladder (OAB), Overactive Bladder Syndrome | Phase 4 | Recruiting | Mansoura University | 480 | 2025-09-01 | 2026-02-18 |
| Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms Tamsulosin Hydrochloride 0.4 mg, Solifenacin Succinate 5 mg, Mirabegron 25 mg - Ureteral Stent-Related Symptom | Phase 3 | Recruiting | Bir Hospital | 189 | 2025-08-30 | 2025-09-08 |
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
| Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes Urodynamic evaluation before and after solifenacin treatment., Urodynamic evaluation before and after mirabegron treatment., Urodynamic evaluation before and after combined treatment with solifenacin and mirabegron. - Overactive Bladder (OAB) | Not applicable | Recruiting | Mackay Medical College | 60 | 2025-07-01 | 2025-06-17 |
| Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females Solifenacin, Tadalafil - Overactive Bladder | Not applicable | Completed | Ain Shams University | 80 | 2025-05-15 | 2025-12-31 |
| Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker Solifenacin, vitamin D, Standard behavioral therapy - Overactive Bladder, Pediatric Disorder | Not applicable | Completed | Xing Liu | 180 | 2024-12-28 | 2025-11-25 |
| Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) Solifenacin, Mirabegron - Urinary Incontinence in Children | Phase 3 | Recruiting | University of Aarhus | 236 | 2024-06-27 | 2026-06-08 |
| Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ. Tamsulosin, solifenacin - Ureteral Stent-Related Symptom, Alpha Blocker | Phase 4 | Completed | Liaquat National Hospital & Medical College | 60 | 2024-06-13 | 2025-08-11 |
| Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry) Solifenacin, Mirabegron, Solifenacin + Mirabegron - Urinary Incontinence in Children | Phase 4 | Active not recruiting | University of Aarhus | 216 | 2024-05-27 | 2026-06-08 |
| Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms Double dose tamsulosin and solifenacin, Single dose tamsulosin and solifenacin - Stent Related Symptoms | Not applicable | Completed | Ain Shams University | 64 | 2024-04-01 | 2025-05-02 |
| Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder electroacupuncture, Solifenacin Succinate Tablets - Overactive Bladder | Not applicable | Recruiting | Yin Ping | 204 | 2023-07-07 | 2025-05-22 |
| Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder Oral Solifenacin 5mg, Transcutaneous Posterior Tibial Nerve Stimulation (TTNS) - Overactive Bladder, Overactive Bladder Syndrome | Not applicable | Completed | Ege University | 34 | 2023-04-18 | 2023-09-05 |
| Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children Solifenacin Succinate 5 MG Oral Tablet [Vesicare], Vitamin D3, Standard urotherapy - Overactive Bladder | Not applicable | Completed | Xing Liu | 303 | 2023-01-15 | 2024-02-06 |
| Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity Solifenacin with vaginal estrogen cream, Combination pharmacotherapy - Urinary Bladder, Overactive, Effect of Drug | Phase 4 | Recruiting | Mackay Memorial Hospital | 200 | 2022-06-16 | 2025-05-09 |
| Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder Combined pharmacotherapy with Solifenacin and Mirabegron, Solifenacin with vaginal estrogen cream, Mirabegron with vaginal estrogen cream - Effect of Drug, Urinary Bladder, Overactive | Phase 4 | Recruiting | Mackay Memorial Hospital | 300 | 2022-06-16 | 2025-05-09 |
Showing 20 of 151. Sign in to see all of them.
Urinary Bladder, Overactive (88) · Urinary Incontinence (22) · Lower Urinary Tract Symptoms (13) · Prostatic Hyperplasia (13) · Urinary Incontinence, Urge (13) · Nocturia (7) · Urinary Bladder Diseases (4) · Urologic Diseases (4) · Parkinson Disease (3) · Multiple Sclerosis (2) · Urinary Bladder Neck Obstruction (2) · Urinary Bladder, Neurogenic (2) · Urinary Tract Infections (2) · Urination Disorders (2) · Breast Neoplasms (1)
Astellas Pharma Inc (30) · Astellas Pharma Europe B.V. (18) · Mansoura University (8) · Far Eastern Memorial Hospital (4) · National Taiwan University Hospital (4) · Astellas Pharma Europe Ltd. (3) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (3) · Jeil Pharmaceutical Co., Ltd. (3) · Loyola University (3) · Mackay Memorial Hospital (3) · Ain Shams University (2) · Asan Medical Center (2) · Astellas Pharma Korea, Inc. (2) · Beni-Suef University (2) · Dong-A ST Co., Ltd. (2)
United States (42) · South Korea (23) · Belgium (21) · United Kingdom (21) · Germany (19) · Poland (18) · Czechia (16) · Taiwan (16) · Denmark (14) · France (14) · Hungary (14) · Italy (14) · Canada (13) · Egypt (13) · Netherlands (13)
Hui-Hsuan Lau, MD (3) · Luise Borch, MD, PhD (2) · Mohammed Hegazy (2) · Thomas Ahlering, MD (2) · Wolfram H Jager, PhD (2) · Ahmed A Shokeir, professor of urology (1) · Ahmed Abdelbary, MD (1) · Ahmed Elhefnawy (1) · Ahmed Elhefnawy, MD (1)
PMID 37160401, PMID 33231929, PMID 21293089, PMID 32007426, PMID 36148895, PMID 10027879, PMID 10188996, PMID 10797303, PMID 11176525, PMID 11412210, PMID 11857671, PMID 12007519, PMID 12579626, PMID 12579627, PMID 12811491, PMID 14693111, PMID 14973214, PMID 16406907, PMID 16753445, PMID 16813910, PMID 17010004, PMID 17574730, PMID 18311486, PMID 18423678, PMID 18565239, PMID 19089891, PMID 19143854, PMID 19220267, PMID 19254402, PMID 19281469, PMID 1939656, PMID 19816919, PMID 19889062, PMID 19930331, PMID 20132203, PMID 20690893, PMID 20707767, PMID 21175373, PMID 21235700, PMID 21371240, PMID 21501328, PMID 21789068, PMID 22008247, PMID 22258963, PMID 22310924, PMID 22531957, PMID 22588142, PMID 22831853, PMID 22981677, PMID 23036134
2008 (5), 2009 (4), 2017 (1), U01HD041249 (1), U10HD041250 (1), U10HD041261 (1), U10HD041267 (1), U10HD054136 (1), U10HD054214 (1), U10HD054215 (1), U10HD054241 (1)